New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.

dc.contributor.author	Mairs, RJ
dc.contributor.author	Zalutsky, MR
dc.coverage.spatial	England
dc.date.accessioned	2015-12-03T18:30:15Z
dc.date.issued	1995-07
dc.identifier	http://www.ncbi.nlm.nih.gov/pubmed/7599061
dc.identifier.issn	0007-0920
dc.identifier.uri	https://hdl.handle.net/10161/11047
dc.language	eng
dc.publisher	Springer Science and Business Media LLC
dc.relation.ispartof	Br J Cancer
dc.subject	3-Iodobenzylguanidine
dc.subject	Antineoplastic Agents
dc.subject	Combined Modality Therapy
dc.subject	Humans
dc.subject	Iodine Radioisotopes
dc.subject	Iodobenzenes
dc.subject	Neuroblastoma
dc.title	New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
dc.type	Journal article
duke.contributor.orcid	Zalutsky, MR\|0000-0002-5456-0324
pubs.author-url	http://www.ncbi.nlm.nih.gov/pubmed/7599061
pubs.begin-page	250
pubs.issue	1
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Duke
pubs.organisational-group	Duke Cancer Institute
pubs.organisational-group	Institutes and Centers
pubs.organisational-group	Pathology
pubs.organisational-group	Radiation Oncology
pubs.organisational-group	Radiology
pubs.organisational-group	School of Medicine
pubs.publication-status	Published
pubs.volume	72

Files

Now showing 1 - 2 of 2

Name:: New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.pdf
Size:: 178.38 KB
Format:: Adobe Portable Document Format

Name:: New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.pdf
Size:: 178.38 KB
Format:: Adobe Portable Document Format